Mankind Pharma Limited (MANKIND)
Please find attached intimation regarding resignation of Statutory Auditors of the Bharat Serums and Vaccines Limited, a matterial wholly owned subsidiary company.
Statutory Auditors S.R. Batliboi & Co. LLP resigned from Bharat Serums and Vaccines Limited, a material wholly owned subsidiary, effective September 28, 2026. Resignation due to initiation of voluntary liquidation proceedings of the subsidiary under Insolvency and Bankruptcy Code, 2016. Auditors confirmed no other material reasons for resignation.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MANKIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MANKIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Mankind Pharma Limited
Important.
The summary above is generated automatically from Mankind Pharma Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.